When Joe Rubinsztain started gMed, he was admittedly young—only a few years removed from medical school— and he just didn’t understand leadership that well.

“I needed to be abreast of everything and understand everything and control everything. And I needed to hire people that would do as I requested. As the company got bigger, understood that in order to grow a big company, you needed to bring in people much better than you, who knew very well what they were doing,” Rubinsztain says.

This was one of three lessons he learned in his 20 years in running gMed, a gastroenterology electronic health record company. The second was to hire people compatible with your goals as an organization. Third, respect the culture of the corporation. Rubinsztain is taking the lessons he learned at gMed, which was acquired by Modernizing Medicine in 2015, for his next act and current gig as CEO of ChronWell.

ChronWell has created an artificial intelligence-backed platform for the workers’ compensation insurance industry. The service helps a worker injured on the job by recommending self-care, on-site care or a health care facility, it follows up with the worker and manages the claim.

Chief Executive spoke to Rubinsztain about why he’s investing in artificial intelligence at ChronWell, and speaks about the trends of consumer-driven healthcare, the lack of risks taken by the insurance industry, and non-traditional consolidation between payers and providers. Below are excerpts from this conversation.

Read more at chiefexecutive.net

Image Credit:   Joe Rubinsztain, CEO of ChronWell

Thanks to Dr. ir Johannes Drooghaag. Follow him on twitter:@DrJDrooghaag

News This Week

Visualizing the Healthtech Revolution

Imagine being a patient in the early 19th century, when all ailments were considered “humors” to be ejected from the body. To restore balance, various techniques such as diets, natural herbs, or bloodletting with [...]

Nano-bot can probe inside human cells

University of Toronto Engineering researchers have built a set of magnetic 'tweezers' that can position a nano-scale bead inside a human cell in three dimensions with unprecedented precision. The nano-bot has already been used [...]